1st Quarter - Termination
TROUTMAN STRATEGIES for BRANDED PHARMACEUTICAL ASSOCIATION
Firm
Income
$10,000
Expenses
—
Terminated
Feb 1, 2008
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Food and drug Administration Amendments Act of 2007 Monitor legislation impacting prescription drugs
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICK ANDERSON | — |
| ROBERT LEEBERN | — |
| BENJAMIN CRAIG NOBLE | — |
Budget/Appropriations BUD
Agriculture, Rural Development, Food and Drug Administration and Related Agencies Act of 2009
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICK ANDERSON | — |
| ROBERT LEEBERN | — |
| BENJAMIN CRAIG NOBLE | — |
Pharmacy PHA
Seek legislative and regulatory support for Desi drugs
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICK ANDERSON | — |
| ROBERT LEEBERN | — |
| BENJAMIN CRAIG NOBLE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.